FDA approval

被引：0
|
作者：
不详
机构：
来源：
GERIATRICS | 2001年 / 56卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] FDA approval
    不详
    GERIATRICS, 2001, 56 (11) : 16 - 16
  • [2] FDA approval
    不详
    GERIATRICS, 2001, 56 (03) : 20 - 20
  • [3] FDA approval for ACTIS
    不详
    MODERN PLASTICS, 2000, 77 (09): : 10 - 10
  • [4] Requirements for FDA Approval
    Basu, Sankar
    PROCEEDINGS OF LIGHT-ACTIVATED TISSUE REGENERATION AND THERAPY CONFERENCE, 2008, 12 : 269 - 269
  • [5] FDA Approval for Vectical
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (05) : 497 - 497
  • [6] FDA Approval of Ipilimumab
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (05) : 552 - 552
  • [7] FDA and drug approval
    Faich, GA
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
  • [8] FDA ALENDRONATE APPROVAL
    MCCARTHY, M
    LANCET, 1995, 346 (8981): : 1028 - 1028
  • [9] FDA Approval for Golimumab
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [10] FDA Approval: Blinatumomab
    Przepiorka, Donna
    Ko, Chia-Wen
    Deisseroth, Albert
    Yancey, Carolyn L.
    Candau-Chacon, Reyes
    Chiu, Haw-Jyh
    Gehrke, Brenda J.
    Gomez-Broughton, Candace
    Kane, Robert C.
    Kirshner, Susan
    Mehrotra, Nitin
    Ricks, Tiffany K.
    Schmiel, Deborah
    Song, Pengfei
    Zhao, Ping
    Zhou, Qing
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4035 - 4039
12345